| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $17.05B | $15.47B | $14.48B |
| YoY Revenue Growth % | +10.2% | +6.9% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $2.94B | $2.67B | $3.20B |
| Operating Margin % | 17.2% | 17.3% | 22.1% |
| Net Income (GAAP) | $2.0M | $1.8M | $2.5M |
| EBITDA (Normalized) | $3.55B | $3.23B | $3.72B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $4.80B | $3.61B | $2.16B |
| Capital Expenditures (CapEx) | $767.2M | $696.1M | $651.4M |
| Free Cash Flow (FCF) | $4.03B | $2.92B | $1.50B |
| FCF Margin % | 23.7% | 18.9% | 10.4% |
| Return on Invested Capital (ROIC %) | 4.8% | 4.7% | 17.8% |
| Cash & Short-Term Equivalents | $1.63B | $1.32B | — |
| Total Debt (Short + Long Term) | $25.55B | $24.71B | $5.50B |
| Total Stockholders' Equity | $24.19B | $21.96B | $11.28B |